Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Kokoh Exa Nusantara Tbk (KOCI) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Kokoh Exa Nusantara TbkTrade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Kokoh Exa Nusantara Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Kokoh Exa Nusantara Tbk trades at Rp108 (market cap 482.48B, 4.55M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume). The key difference: Kokoh Exa Nusantara Tbk is far larger — about 2.9× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Kokoh Exa Nusantara Tbk is more actively traded (4.55M versus 62.5K). Which is the better fit depends on your goals.

KOCIOBAT
Market Cap
482.48B164.65B
Volume
4.55M62.5K
Lot
45.53K625
Turnover
494.6M15.03M
Average Price
108.62240.55
Value
494.6M15.03M
Indicative Equilibrium Price
108238
Indicative Equilibrium Volume
1.27K100

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

KOCI
View details
OBAT
View details

About Kokoh Exa Nusantara Tbk

PT Kokoh Exa Nusantara Tbk (the Entity) was established based on Notarial Deed No. 173, dated July 31, 2019 of Dwi Rossulliati, S.H., notary in Mojokerto Regency. The Entity started its commercial operations in 2020. PT Exa Nusa Persada is its ultimate parent entity.

Read more on KOCI

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT